RBOT (Vicarious Surgical) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Vicarious Surgical is: No Data: Cannot be evaluated.

Competitive Comparison of Vicarious Surgical's Risk Assessment

For the Medical Devices subindustry, Vicarious Surgical's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicarious Surgical's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Vicarious Surgical's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Vicarious Surgical (NYSE:RBOT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Vicarious Surgical Risk Assessment Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicarious Surgical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

78 Fourth Avenue, Waltham, MA, USA, 02451

Website

https://www.vicarioussurgical.com

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Executives

Adam David Sachs	director, 10 percent owner, officer: President and CEO	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa	director, 10 percent owner, officer: Chief Technology Officer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
William John Kelly	officer: CFO and Treasurer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola	officer: Chief Operating Officer	TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
June Morris	officer: CLO, General Counsel and Sec	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Khosla Ventures Opportunity Ii, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Associates Ii, Llc	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho	director	UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang	director	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr	director	C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss	director	C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Shrikant Patnaik	other: Principal	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop	director	C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803
Barry Stuart Greene	10 percent owner	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451